Skip to main content

Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC).

Publication ,  Conference
Hochheiser, L; Hornberger, JC; Turner, M; Lyman, GH
Published in: Journal of Clinical Oncology
May 20, 2018

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e12519 / e12519

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hochheiser, L., Hornberger, J. C., Turner, M., & Lyman, G. H. (2018). Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC). In Journal of Clinical Oncology (Vol. 36, pp. e12519–e12519). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.e12519
Hochheiser, Lou, John C. Hornberger, Michelle Turner, and Gary H. Lyman. “Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC).” In Journal of Clinical Oncology, 36:e12519–e12519. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.e12519.
Hochheiser L, Hornberger JC, Turner M, Lyman GH. Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e12519–e12519.
Hochheiser, Lou, et al. “Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC).Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. e12519–e12519. Crossref, doi:10.1200/jco.2018.36.15_suppl.e12519.
Hochheiser L, Hornberger JC, Turner M, Lyman GH. Comparative analysis of multigene assays (MGA) effects on chemotherapy (CT) de-escalation for women with N0, ER+ early stage breast cancer (ESBC). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. e12519–e12519.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2018

Volume

36

Issue

15_suppl

Start / End Page

e12519 / e12519

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences